MODERATOR
:
SPEAKER
(S):
Koo-Whang Chung, MPH, Health Scientist, Centers for Disease Control and Prevention
Kevin Land, MD, VP of Clinical Services, Blood Systems, Inc.
Barbee Whitaker, PhD, Director, Research and AABB Center for Patient Safety, AABB
Mark Fung, MD, PhD, Medical Director, Blood Bank and Transfusion Services, Fletcher Allen Health Care/ Univ. of Vermont
Description
This event provides an opportunity for a panel to represent various public and private perspectives and to discuss the current landscape in biovigilance. Included will be representatives from the CDCs National Healthcare Safety Network - Hemovigilance Module, AABBs Biovigilance Working Group who developed the definitions and content of the Hemovigilance Module, AABBs Donor Hemovigilance Working Group, and AABBs Patient and Donor Safety Center. Questions for the discussion are submitted before the scheduled session via the AABB website starting in August, at kiosks in the Cyber Connection located in the Colorado Convention Center and during the session.
LEARNER OUTCOMES:
-
Describe the rationale behind the development of the hemovigilance forms and definitions used in the Hemovigilance Module.
-
Explain and describe the CDCs hemovigilance protocol and how to use the Hemovigilance Module of the National Healthcare Safety Network (NHSN).
-
Review other proposed or existing biovigilance systems.
-
Review the services provided by AABBs Patient and Donor Safety Center and the confidentiality provisions the center affords.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.